Based on recent data, Oruka Therapeutics, Inc. (ORKA) shows an Average True Range (ATR) of 1.97 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 507.26K, indicating liquidity. These fundamental metrics provide insight into ORKA's underlying financial health and market activity.
| ATR | 1.97 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 507.26K |
| Avg Vol (10 Days) | 355.36K |
Oruka Therapeutics, Inc. (ORKA) technical indicators as of February 26, 2026: the SMA 20 is 5.62%, SMA 50 at 10.67%, and SMA 200 at 63.03%. The RSI 14 value is 62.04, suggesting its current momentum. These technical analysis signals help assess ORKA's price trends and potential future movements.
| SMA 20 | 5.62% |
| SMA 50 | 10.67% |
| SMA 200 | 63.03% |
| RSI 14 | 62.04 |
Oruka Therapeutics, Inc. (ORKA) stock performance overview as of February 26, 2026: The 52-week high is $36.53 (currently -3.37% below), and the 52-week low is $5.49 (currently 543.21% above). Over the past year, ORKA's performance is 163.73%, compared to the S&P 500's 10.91% change.
| 52-Week High | 36.53 |
| 52-Week High Chg | -3.37% |
| 52-Week Low | 5.49 |
| 52-Week Low Chg | +543.21% |
| S&P 500 52-Week Chg | 10.91% |
According to market data, Oruka Therapeutics, Inc. (ORKA) stock's recent performance metrics show that over the last month, ORKA is 17.09%, with a Year-to-Date (YTD) performance of 9.63%. Over the past year, the stock has seen a 163.73% change. These figures summarize ORKA's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 36.53 | 36.53 | 36.53 | 36.53 | 36.53 | 36.53 |
| Low | 31.08 | 31 | 25.23 | 14.34 | 5.49 | 25.23 |
| Performance | +8.28% | +17.09% | +20.92% | +141.32% | +163.73% | +9.63% |
According to current financial data, ORKA stock's P/E (TTM) ratio is -14.15, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for ORKA, including P/S (N/A), P/B (3.18), and P/FCF (-15.53), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ORKA | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -14.15 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | N/A | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 3.18 | -0.49 | 9 | 5.26 |
| P/FCF (TTM) | -15.53 | -19.93 | -253.28 | 30.85 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep